Sign in

CIK 0001127537

  • Non-accelerated filer
  • Smaller reporting company

Pulmonx Corp

Sign in to watch
Ticker
LUNG
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-364-0400
Business address
700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Former names
PULMONX
  1. 4 Planned sale President and CEO sold 15,000 shares at $12.68 ($190,200)
  2. 4 Planned sale President and CEO sold 10,000 shares at $12.68 ($126,800)
  3. 4 Open-market sale Chief Financial Officer sold 4,222 shares at an average $11.49 ($48,507)
  4. 4 Grant or award Director acquired 12,620 shares (grant or award)
  5. 4 Open-market sale Chief Commercial Officer sold 2,845 shares at $11.48 ($32,661)
  6. 4 Grant or award Director acquired 12,620 shares (grant or award)
  7. 4 Grant or award Director acquired 12,620 shares (grant or award)
  8. 4 Open-market sale General Counsel sold 3,776 shares at $11.48 ($43,348)
  9. 4 Open-market sale President and CEO sold 6,533 shares at an average $11.48 ($75,009)
  10. 4 Grant or award Director acquired 12,620 shares (grant or award)
  11. 4 Grant or award Director acquired 12,620 shares (grant or award)
  12. 4 Grant or award Director acquired 12,620 shares (grant or award)
  13. 4 Grant or award Director acquired 12,620 shares (grant or award)
  14. 4 Open-market sale Chief Financial Officer sold 1,264 shares at $11.03 ($13,942)
  15. 4 Open-market sale Chief Commercial Officer sold 1,206 shares at $11.03 ($13,302)
  16. 4 Open-market sale General Counsel sold 1,264 shares at $11.03 ($13,942)
  17. 4 Open-market sale President and CEO sold 2,895 shares at $11.03 ($31,932)
  18. 4 Open-market sale President and CEO sold 3,631 shares at $5.93 ($21,532)
  19. 4 Open-market sale General Counsel sold 1,069 shares at $5.93 ($6,339)
  20. 4 Open-market sale Chief Commercial Officer sold 1,055 shares at $5.93 ($6,256)

Page 6 of 12 · 229 filings